Connect with us:

Facebook Twitter RSS

News & Updates

02 Dec 2015

European cancer centres finally united in long-term collaborative partnerships

For many decades, cancer research in Europe has been heavily fragmented, inefficient and duplicating work. Now, long-term collaborations have been generated between cancer centres which will carry a new phase of cooperation into the future.

Five years ago, 28 top cancer research institutes and organisations in the continent came together in a unique EU-financed collaboration as the ‘EurocanPlatform’ to share infrastructure and work together on projects.

Predicted to increase significantly globally as the population ages, cancer places a substantial burden on healthcare systems particularly regarding surveillance and recurrent treatment.

“We’re faced with this growing cancer burden and at the same time we’re confronted with the spiralling costs of cancer treatment and care”, says Christopher Wild, Director of the International Agency for Research on Cancer (IARC).

There is now an urgent need to meet these challenges by developing long-term strategies to speed up the translation of basic discoveries into clinical and preventive applications.

European Commissioner for Research, Innovation and Science, Carlos Moedas, stated at the project’s final Annual Meeting in Brussels on 3 November 2015 that patients should be at the centre of research. Moving to personalised medicine will lead to challenges requiring a link to digital technology and new legal and ethical standards to support international collaborations and compilation of data will be required. There is a need for cancer care that is innovative and cost-effective, and the cancer community needs to give advice and support.
Now in its final months, the EurocanPlatform project has produced some important outcomes that are hoped to impact cancer patient outcomes and reduced mortality.

Cancer Core Europe (CCE), a recently established long-term initiative between six leading cancer centres from the EurocanPlatform (Institute Gustave Roussy in Paris, Cambridge Cancer Centre, Netherlands Cancer Institute in Amsterdam, Karolinska Institutet in Stockholm, Vall d’Hebron Institute of Oncology in Barcelona and the German Cancer Research Centre (DKFZ) in Heidelberg).

This aims to create a single virtual ‘e-hospital’ which will provide powerful translational platforms, inter-compatible clinical molecular profiling laboratories with a robust underlying computational biology pipeline, standardised imaging as well as early clinical trial structures to address personalised cancer medicine. Each centre has invested funds towards this important goal.

Spearheaded by Professor Alexander Eggermont and Professor Otmar Wiestler, CCE has its roots running through the project and all the way back to 2002, when Commissioner Philippe Busquin promoted the creation of the European Cancer Research Area, saying “Europe was not delivering the outcomes expected by healthcare professionals and citizens, and there was a need to create a joint European strategy for cancer research.”

EurocanPlatform’s Scientific Coordinator Julio Celis of the Danish Cancer Society Research Centre said: “I believe CCE represents the first organised step in this direction….hopefully, CCE will be a precursor to a virtual European Cancer Institute.”

Commissioner Carlos Moedas said "As I see it, digital technologies and personalised medicine will provide many of the answers we need to fight cancer in the 21st century. There is a lot we can explore, with the ultimate goal of bringing the digital and the physical together to fight cancer, so that fewer citizens become patients and more patients become survivors".

Following on from the initial success of CCE, Dr Christopher Wild of IARC plans to create a counterpart initiative: Cancer Prevention Europe.

He said, “To really address that challenge we needed not only to focus on improving treatment which is essential, but also trying to address the prevention of the disease and its early detection, and having a more integrated approach across those different areas.”

“I was impressed at the progress that had been made between these major cancer institutes together to form what is now called the Cancer Core Europe. I wanted to introduce a kind of ‘twin-track’ approach, if you like, saying let’s try a similar type of approach regarding cancer prevention.”

Coordinating approaches across centres in cancer prevention is the perfect complement to CCE, giving a symmetrical, sustainable approach to tackling cancer in Europe.

Ulrik Ringborg of the Karolinska Institutet, the project’s coordinating partner, remarked: ‘The EurocanPlatform has created a multidisciplinary environment to structure research collaboration between preclinical and clinical cancer research centres for translational research aimed at personalized cancer medicine. We are delighted that the EurocanPlatform has been able to deliver important sustainable outcomes which will strengthen Europe’s ability to innovate in cancer research.”

About the EurocanPlatform: The EurocanPlatform is an EU-funded Network of Excellence linking 23 cancer research centres and five cancer organisations aiming at institutional collaborations in translational cancer research to innovate in prevention, early detection and therapeutics. The centres are sharing infrastructures and collaborating on projects to help advance cancer research and treatment. Funding: The EurocanPlatform is funded by the European Union Seventh Framework Programme (FP7/2011-2015) under grant agreement n° 260791. www.eurocanplatform.eu

Learn more about Cancer Core Europe and Cancer Prevention Europe,

More publications

14 Dec 2016: Preserving fertility in girls and young women with cancer “haphazard” say experts 23 Dec 2015: 'Hematological Malignancies: from Mechanisms to Therapy' symposium - March 9/12, 2016 - Milan 19 Nov 2015: SiRIC-Curie Call for translational research group leaders, Paris, France 20 Oct 2015: IARC Fellowships for Cancer Research 03 Aug 2015: Optimizing sharing of hospital biobank samples: new EurocanPlatform paper published in Science Translational Medicine 17 Jul 2015: 3rd EurocanPlatform Summer School in Translational Cancer Research: Portugal, 12 – 16 October 2015 17 Jul 2015: NCT Heidelberg School of Oncology Fellowship Program in Translational Cancer Research - Call for applications 01 Jul 2015: EurocanPlatform project engages directly with patient groups at ECPC AGM 19 Jun 2015: EurocanPlatform Translational Research Course 12th - 16th October - Save the Date! 13 May 2015: Catch up on all the latest from the EurocanPlatform project in the May 2015 Newsletter 14 Apr 2015: New EurocanPlatform paper published in PLOS One 31 Mar 2015: Launch of personalised medicine survey: Literacy among healthcare professionals 30 Mar 2015: OECI Cancer Days 2015 in Porto, Portugal 10 Mar 2015: Workshop on circulating biomarkers in cancer 19 Feb 2015: Meeting report from the second EurocanPlatform summer school on translational cancer research published in ecancermedicalscience 27 Jan 2015: The January 2015 Newsletter is here! 21 Jan 2015: Most types of cancer not due to “bad luck”, says IARC 06 Jan 2015: Brand new videos available from the 2nd Translational Research Course 08 Dec 2014: New conference report for the EurocanPlatform Chemoprevention Meeting published in ecancermedicalscience 20 Nov 2014: The November 2014 Newsletter is here! 13 Nov 2014: IARC/WHO Fellowships 05 Nov 2014: Research course on circulating tumor cells (CTC) at the Karolinska Institute 28 Oct 2014: Eighth Belgian Symposium on the Integration of Molecular Biology Advances into Oncology Clinical Practice 03 Oct 2014: Core values for a new cancer culture: six centres create Cancer Core Europe 01 Sep 2014: EurocanPlatform paper published in the Journal of Oncology Practice 18 Aug 2014: 4th Annual meeting of EurocanPlatform project, October 25-26th 2014 04 Aug 2014: EurocanPlatform Translational Cancer Research Summer Course, Portugal, October 20-24, 2014 31 Jul 2014: The Summer 2014 Newsletter is here! 18 Jun 2014: Role for an experienced scientist available at the Curie Institute 20 May 2014: New science policy paper published in Molecular Oncology 19 Feb 2014: Workshop on "Tissue-based Biomarkers for Advancement of Personalized Cancer Treatment" 21 Jan 2014: The second Advanced Lecture Course on Translational Cancer Research 21 Jan 2014: OECI and ECPC - How Uniform Is Cancer Care? February 18th 2014 31 Oct 2013: FDA pulls ponatinib approval due to blood clots and narrowing of blood vessels 22 Oct 2013: Publications from within EurocanPlatform - Year 2 09 Oct 2013: IARC: Postdoctoral fellowships for training in cancer research 12 Sep 2013: VHIO-Fritz Bender Foundation joint International Symposium 13 Aug 2013: HPV vaccine could also prevent oropharyngeal cancer, says IARC 13 Aug 2013: New ECPC Board of Directors 11 Jun 2013: EAPM Members Update: Discussion on the Data Protection Legislation 21 May 2013: Growing call to abandon impact factors 29 Apr 2013: New partnership between IARC and CRI to spur cancer research in Thailand and across South-East Asia 11 Apr 2013: OECI 2013 Oncology Days - including EurocanPlatform Session 08 Mar 2013: Spreading the cancer prevention message in Sierra Leone 25 Feb 2013: EAPM: Access to health data is essential for the development of new treatments 20 Feb 2013: Access to health data is essential for the development of new treatments, says European Alliance of Personalised Medicine 23 Jan 2013: Course in cancer genomics at EBI 26 Oct 2012: Scientists discover potential new 'roots' of breast cancer 19 Sep 2012: Personalised medicine promises radical improvements to healthcare in Europe